Want to join the conversation?
Maker of surgical devices and systems $MDT said that the Covidien integration is delivering robust operating leverage as the company realizes its committed cost synergies, which combined with the financial leverage drove high teen EPS growth and double-digit EPS leverage in 3Q16.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.